Intermittent Treatment With MEK Inhibitors in Patients With Oncogenic RAF-Driven Tumors: A Potential Strategy to Manage Toxicity and Maintain Efficacy.

Overview

authors

Chapman, Paul

publication date

November 1, 2018

published in

JCO precision oncology Journal

Identity

Scopus Document Identifier

85071160380

Digital Object Identifier (DOI)

10.1200/PO.18.00038

PubMed ID

35135118

Additional Document Info

has global citation frequency

2

volume

2